Dark Forest Capital Management’s Fate Therapeutics FATE Stock Holding History

Dark Forest Capital Management’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-61,220	Closed	-$101K	–	1295
2024 Q4	$101K	Buy	61,220 +34,371	+128%	+$86.6K	0.01%	862
2024 Q3	$94K	Buy	26,849 +7,784	+41%	+$30.3K	0.01%	922
2024 Q2	$62.5K	Buy	+19,065	New	+$83.5K	0.01%	629
2023 Q4	–	Sell	-425,901	Closed	-$903K	–	687
2023 Q3	$903K	Buy	425,901 +352,204	+478%	+$1.17M	0.07%	460
2023 Q2	$351K	Buy	73,697 +58,166	+375%	+$321K	0.03%	765
2023 Q1	$88.5K	Buy	+15,531	New	+$93.7K	0.02%	699
2022 Q1	–	Sell	-216	Closed	-$13K	–	1429
2021 Q4	$13K	Sell	216 -66	-23%	-$3.74K	﹤0.01%	829
2021 Q3	$17K	Buy	+282	New	+$22.1K	0.01%	868

Other funds holding FATE

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Dark Forest Capital Management's FATE Position: Q1 2025 in Review

Dark Forest Capital Management sold out of Fate Therapeutics (FATE) in Q1 2025, closing a stake of 61,220 shares — an estimated $101K sold.

Dark Forest Capital Management first reported a position in FATE in Q3 2021 and held it in 8 quarters. The position peaked at $903K in Q3 2023. 132 funds tracked by Wall St. Rank hold FATE as of Q1 2025.

Dark Forest Capital Management reported no remaining Fate Therapeutics position as of Q1 2025 after selling out during the quarter.
Dark Forest Capital Management sold 61,220 Fate Therapeutics shares in Q1 2025, an estimated $101K.
Dark Forest Capital Management first reported a position in Fate Therapeutics in Q3 2021 and held it in 8 quarters.
Dark Forest Capital Management's Fate Therapeutics position peaked at $903K in Q3 2023.
132 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2025.

Based on Dark Forest Capital Management's 13F filing for Q1 2025, filed 15 May 2025.